Globus Medical Inc. (NYSE:GMED), a leading medical device company specializing in musculoskeletal disorders, has been making waves in the healthcare sector with its recent acquisition of Nevro Corp ...

RFG is managed by Invesco, and this fund has amassed over $324.79 million, which makes it one of the average sized ETFs in the Style Box - Mid Cap Growth. This particular fund, before fees and ...

If you're the kind of investor who would rather try and beat the market through good stock selection, then smart beta funds are your best choice; this fund class is known for tracking non-cap ...

Under the terms of the agreement, Globus Medical will acquire all shares of ... We are a national class action securities firm with a successful track record in trial and appellate courts ...

DexCom (DXCM) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.50 per share a year ago. These figures are ...

Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read ...

Believe me when I say I’ve been waiting nearly three months to say these words: Tracker is back-er. The day that fans of CBS’s hit Justin Hartley series have been waiting for since December ...

NYSE GMED opened at $83.99 on Friday. Globus Medical has a fifty-two week low of $49.33 and a fifty-two week high of $94.93. The stock has a market cap of $11.44 billion, a PE ratio of 125.36, a P ...

Get Our Latest Research Report on Globus Medical Globus Medical Stock Up 0.0 % Shares of GMED opened at $84.04 on Friday. The stock has a market cap of $11.44 billion, a price-to-earnings ratio of ...